Abstract:Background: The role of surgical resection remains controversial in small cell lung cancer (SCLC) although there are some retrospective and population-based studies indicate that patients with very early stage SCLC has longer survival compared with those not given surgery. The speciﬁc aim of this study was to identify the survival beneﬁt of surgery for patients with Stage IA-IIB SCLC and nomogram predictive model was created to select patients who are eligible to surgery. Methods: Patients diagnosed with stage IA-IIB SCLC between 2004 and 2014 were selected from the SEER database. The primary endpoint was overall survival. Multivariate Cox proportional regression and coefficients of the predictors were calculated. A nomogram was constructed for predicting 1- and 3-year overall survival probability. All statistical analysis was performed with R software. Results: 2246 patients with stage I-II were enrolled. 618 (27.5%) received surgery and 1628 (72.5) not. Unadjusted median overall survival (OS) was 23 months (95% CI: 21-24), which was 35 months (95% CI: 31-44) vs. 19 months (95% CI: 18-21) in surgery and non-surgery groups respectively (p <0.0001). We used a propensity score to balance observed covariates. OS benefit was observed in all subgroups between the surgery and non-surgery group except in the non-White race, well or moderately grading, stage IIA or IIB and N1 lymph involvement. Multivariate Cox proportional hazards regression analysis showed a survival benefit in the surgery group compared with non-surgery group no matter balanced by propensity score weighting or not. The competing-risks nomogram was built for predicting 1-year and 3-year survival. The age, tumor size, extent of tumor, N0/1 and surgery with radiation and chemotherapy were introduced as variables. The calibration of internal validation for predicting survival at 1 and 3-year by this nomogram-predicted probability was identical to the actual probability. Conclusions: Surgery was proved to benefit patients with stage IA-IIB SCLC by this relatively large number population-based study and a nomogram built from a parametric survival model from the SEER database can be used to predict which patients with stage IA-IIB SCLC may beneﬁt from surgery. Legal entity responsible for the study: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology Medicine, Peking University Cancer Hospital & Institute. Funding: National Natural Science Foundation of China, Award ( 81401914) and Beijing Municipal Administration of Hospitals' Youth Programme (20161112). Disclosure: All authors have declared no conflicts of interest.

Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis

Safety and Effectiveness of Neoadjuvant Immunotherapy Combined with Chemotherapy Followed by Surgical Resection in Patients with Stage I-IIIA Small-Cell Lung Cancer: a Retrospective Single-Arm Clinical Trial.

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer after Small Cell Lung Cancer: A Population-Based Study

[Survival Benefit of Primary Site Surgery Acquired by Stage Ⅳ Non-Small Cell Lung Cancer: a Retrospective Study Based on Seer Database].

Retrospective study of surgical resection in the treatment of limited stage small cell lung cancer

Propensity Score Matched Analysis for the Role of Surgery in Stage Ⅲ Small Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: a Population Study of the US SEER Database and a Chinese Hospital.

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.

Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation

Real-world Surgical Treatment Patterns and Clinical Outcomes in Patients with Stages IA–IIIA Non-Small Cell Lung Cancer: a Retrospective Multicentric Observational Study Involving 11,958 Patients

Role of Surgery in Potentially Resectable Small‐Cell Lung Cancer Based on the Eighth Edition of the TNM Classification: A Population Study of the US SEER Database

Role of Surgery in a Case-Control Study of Patients with Clinical Stage IIIA Small Cell Lung Cancer

Excellent Survival of Pathological N0 Small Cell Lung Cancer Patients Following Surgery

The consideration of surgery on primary lesion of advanced non-small cell lung cancer

Effects of Surgery on Survival of Early-Stage Patients with SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database.

Closing the RCT Gap—A Large Meta-Analysis on the Role of Surgery in Stage I–III Small Cell Lung Cancer Patients

Surgical Intervention May Be a Therapeutic Option for NSCLC Patients with AJCC Stage IV: a Large Population-Based Study.

Benefits of Surgery in the Multimodality Treatment of Stage IIB-IIIC Small Cell Lung Cancer

Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.

Propensity Score Matching Analysis for the Role of Surgery in Small Cell Lung Cancer.

Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database

Nomogram for Predicting the Benefit of Surgery for Stage IA-IIB Small Cell Lung Cancer.